GMP virus manufacturing

ABL has a long history of development and manufacturing of preclinical and clinical virus-based biologics. From 30 years of groundbreaking work with HIV to supporting the latest gene therapy technologies, ABL offers a comprehensive portfolio of services for the effective design, development, manufacturing and analytical testing of vaccine and virus vector products. ABL's adherent and suspension platforms include: • Single-use bioreactor systems (SUBs) • iCELLis 500+ and iCELLis Nano systems • HYPERStacks, roller bottles and cell factories We are a biomanufacturing corporation with global facilities, suites and production platforms focused on accelerating your life changing innovation to market. Product types: • Gene therapies • Oncolytics • Vaccines • Immunotherapies ABL has experience producing numerous viral vectors, including: • HSV-1 • Vaccinia (and MVA) • VLPs • Zika • CMV • Lentivirus (and retrovirus) • Adenovirus • AAV • VSV Start the discussion with us to see how we can forge a powerful partnership. Contact us here: https://ablinc.com/about-abl/contact-us/